Novartis AG (NVS)
Q2 2012 Earnings Call
July 19, 2012 8:00 am ET
ExecutivesJoseph Jimenez - Chief Executive OfficerSusanne Schaffert - Head of Oncology - Novartis Pharma GermanyJonathan Symonds - Chief Financial OfficerDavid Epstein - Division Head of Novartis PharmaceuticalsBrian Mcnamara - Division Head of Novartis OtcKevin J. Buehler - President, Chief Executive Officer, and ChairmanAndrin Oswald - Division Head of Vaccines & DiagnosticsJeffrey George - Division Head of Sandoz and Member of Executive CommitteeAnalystsTim Anderson - Sanford C. Bernstein & Co., LLC., Research DivisionAlistair D. Campbell - Berenberg Bank, Research DivisionAlexandra Hauber - JP Morgan Chase & Co, Research DivisionMatthew Weston - Crédit Suisse AG, Research DivisionNaresh Chouhan - Liberum Capital Limited, Research DivisionMichael Leuchten - Barclays Capital, Research DivisionAndrew C. Weiss - Bank Vontobel AG, Research DivisionSeamus Fernandez - Leerink Swann LLC, Research DivisionFlorent Cespedes - Exane BNP Paribas, Research DivisionAndrew S. Baum - Citigroup Inc, Research DivisionPeter Verdult - Morgan Stanley, Research DivisionFlorian GaiserPresentationOperator
Previous Statements by NVS
» Novartis AG's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Novartis AG's CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Novartis AG's CEO Discusses Q3 2011 Results - Earnings Call Transcript
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV